About this publication
Label & Literature is an independent publication about non-surgical aesthetic medicine. It reads the regulatory record and the published literature, and reports what each one does and does not establish.
The two words are the method
The label is the regulatory record: what the US Food and Drug Administration has approved or cleared, for which uses, in which age group, with which warnings, and what it has since said in safety communications, recalls and warning letters. A label is a public document and it is unusually precise about the limits of what a product may be sold to do.
The literature is the published research record: randomised trials, systematic reviews, imaging follow-up studies, adverse-event series. It answers a different question — not what a product may be sold to do, but what has actually been measured in people, in how many people, and for how long.
Most marketing in this field lives in the gap between those two records. A treatment can be genuinely approved and still have no evidence at all behind the specific promise printed beside its price. This publication holds each claim against both records and reports where the claim stops being supported.
What it covers
Non-surgical aesthetic medicine: injectables, light- and energy-based devices, and the treatments sold alongside them. For each one, the same eight questions get answered in the same order — what it actually is, what it is approved for, what the evidence establishes, where the evidence runs out, how it is priced, what the risks are and whether they can be undone, what the record supports asking a provider, and what the alternatives are, including doing nothing.
The section headed Where the evidence runs out is a required part of every article, not an optional one. A demonstrated effect on tissue is not the same finding as a benefit measured in people, and separating those two is most of the work.
Coverage is national and general: treatments and the documents behind them, sorted by subject rather than by city.
How it is organised
The front page is the register: one table holding fifteen treatments against their regulatory status, their best available evidence, and the point where that evidence stops. Articles expand individual rows. There is no separate index and no reverse-chronological feed, because a reference is more useful sorted by subject than by the day something was written.
Three standing pages support the articles. How we read the evidence sets out the source ranking and the six-rung scale used to mark how strong a claim’s support is. The glossary defines the technical and regulatory terms, each with a stable link so an article can point straight at one. Where to report lists the official channels and states what each of them can and cannot act on.
Who is credited
Work here is attributed to the publication rather than to a person. The method page stands in place of a byline: it tells you which documents were ranked highest and how a claim was graded, which is the part of a byline that carries information.
Where a study is cited, it is cited the way a bibliography cites it — by journal, year and institution — so it can be looked up. Researchers named in those citations are the authors of the document being cited, and the citation is the whole of the credit.
The two dates on every page
Reviewed is the date the page was last read through in full. Evidence current to is the date the underlying sources were last checked against their originals. They are separate because a page can be re-read without any source having moved, and a source can move without anyone here noticing for a while.
Regulatory documents change. A safety communication can appear, an indication can be added, a device clearance can be withdrawn. Both dates are printed so an ageing page is visible as an ageing page rather than reading as current.
What this can and cannot answer
A published record can tell you what has been measured, in how many people, and with what result. It cannot tell you what will happen to you. Whether a treatment suits you depends on your medical history, the medicines you take, and what the skin or tissue in that area is actually doing. Establishing that is what a consultation with a licensed clinician is for.
Where the evidence for something is weak, contested or absent, the page says so in those words. That is the part readers cannot get from a page that is also selling the treatment, and it is why the last column of the register is the one worth reading first.
Corrections are welcome, and a source that has been misread is worth more to this publication than a compliment. The contact page is a form with a route for exactly that.
Reviewed: 8 August 2026 · Evidence current to: 8 August 2026